Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02QBT
|
||||
Former ID |
DIB001603
|
||||
Drug Name |
AZETIRELIN
|
||||
Synonyms |
Azetirelin < Rec INN >; YM-14673 (dihydrate); Nalpha-[(S)-2-Azetidinone-4-carbonyl]-L-histidyl-L-prolinamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Phase 3 | [544285] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H20N6O4
|
||||
Canonical SMILES |
NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]3C<br />C(=O)N3
|
||||
InChIKey |
WBGUMUGCONUXFK-DCAQKATOSA-N
|
||||
CAS Number |
CAS 95729-65-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Thyrotropin-releasing hormone receptor | Target Info | Modulator | [531635], [533643] | |
PANTHER Pathway | Thyrotropin-releasing hormone receptor signaling pathway | ||||
References | |||||
Ref 531635 | Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36. | ||||
Ref 533643 | Intestinal absorption of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. II. In situ and in vitro absorption characteristics of azetirelin from the rat intestine. Biol Pharm Bull. 1995 Jul;18(7):976-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.